Literature DB >> 15173318

Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.

Luguo Sun1, Lanying Liu, Xiang-Jiao Yang, Zhenguo Wu.   

Abstract

In a yeast two-hybrid screen using the full-length Akt as bait, we found that prohibitin 2 (PHB2) specifically interacts with Akt. The C terminus of Akt (amino acids 413-480) and a central region of PHB2 (amino acids 120-232) are responsible for their mutual interaction. PHB2 acts as a transcriptional repressor in cells. PHB2 interacts with both MyoD and MEF2, and represses both MyoD- and MEF2-dependent gene transcription. Furthermore, binding of PHB2 to both MyoD and MEF2 significantly decreases upon myogenic differentiation. When stably expressed in C2C12 myogenic cells, PHB2 inhibits myogenin induction and phenotypic muscle differentiation. PHB2 was found to specifically recruit histone deacetylase 1, which is probably responsible for its repressive activity. Co-expression of Akt can partially reduce PHB2 binding to MyoD and relieve the repressive effect of PHB2 on myogenic reporters, which could be one of the mechanisms underlying Akt-mediated MyoD activation and accelerated muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173318     DOI: 10.1242/jcs.01142

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  41 in total

1.  Formation of membrane-bound ring complexes by prohibitins in mitochondria.

Authors:  Takashi Tatsuta; Kirstin Model; Thomas Langer
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

Review 2.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  JAK2/STAT2/STAT3 are required for myogenic differentiation.

Authors:  Kepeng Wang; Chihao Wang; Fang Xiao; Haixia Wang; Zhenguo Wu
Journal:  J Biol Chem       Date:  2008-10-02       Impact factor: 5.157

Review 4.  Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways.

Authors:  Nadège Zanou; Philippe Gailly
Journal:  Cell Mol Life Sci       Date:  2013-04-04       Impact factor: 9.261

5.  Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

Authors:  B Joshi; S Rastogi; M Morris; L M Carastro; C DeCook; E Seto; S P Chellappan
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

6.  Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry.

Authors:  Ekaterina Boyarchuk; Philippe Robin; Lauriane Fritsch; Véronique Joliot; Slimane Ait-Si-Ali
Journal:  J Vis Exp       Date:  2016-05-17       Impact factor: 1.355

7.  Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration.

Authors:  Nadège Zanou; Olivier Schakman; Pierre Louis; Urs T Ruegg; Alexander Dietrich; Lutz Birnbaumer; Philippe Gailly
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

8.  Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.

Authors:  Kewei Ma; Jonathan K L Chan; Guang Zhu; Zhenguo Wu
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 9.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

10.  Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes.

Authors:  Christopher R Lucas; Hector M Cordero-Nieves; Robert S Erbe; Jaclyn W McAlees; Sumeena Bhatia; Richard J Hodes; Kerry S Campbell; Virginia M Sanders
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.